Genital Diseases, Female  >>  cabazitaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cabazitaxel / Generic mfg.
NCT01747239 / 2012-001224-35: Cabazitaxel in Platinum Refractory Ovarian Cancer

Terminated
2
4
Europe
Cabazitaxel
Vejle Hospital, Sanofi
Ovarian Cancer
07/14
07/14

Download Options